Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Gut|March 21, 2014
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMSDan Rosmarin, Claire Palles, Alistair Pagnamenta, et al.The Journal of Pathology|December 23, 2024
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysisLydia A Schoenpflug, Aikaterini Chatzipli, Korsuk Sirinukunwattana, et al.Gut|July 22, 2020
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learningKorsuk Sirinukunwattana, Enric Domingo, Susan D Richman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2024
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG StudiesEnric Domingo, Caroline Kelly, Jennifer Hay, et al.Gut|September 30, 2019
Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratificationSam O Kleeman, Viktor H Koelzer, Helen Js Jones, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2011
KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancerJeanne Tie, Lara Lipton, Jayesh Desai, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2022
Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical DataNatalie C Fisher, Ryan M Byrne, Holly Leslie, et al.Cell|September 12, 2024
TEX264 drives selective autophagy of DNA lesions to promote DNA repair and cell survivalPauline Lascaux, Gwendoline Hoslett, Sara Tribble, et al.The Lancet. Oncology|February 1, 2024
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysisAnja L Frei, Anthony McGuigan, Ritik R A K Sinha, et al.British Journal of Cancer|July 21, 2020
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxiaStephanie G Craig, Matthew P Humphries, Matthew Alderdice, et al.Pageof 12